Literature DB >> 30414854

Eosinophil progenitor levels correlate with tissue pathology in pediatric eosinophilic esophagitis.

Justin T Schwartz1, David W Morris1, Margaret H Collins2, Marc E Rothenberg1, Patricia C Fulkerson3.   

Abstract

Entities:  

Year:  2018        PMID： 30414854      PMCID： PMC6408963          DOI： 10.1016/j.jaci.2018.10.036

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  9 in total

1.  Immunolocalization of CD34 in nasal polyposis. Effect of topical corticosteroids.

Authors:  Y K Kim; M Uno; D L Hamilos; L Beck; B Bochner; R Schleimer; J A Denburg
Journal:  Am J Respir Cell Mol Biol       Date:  1999-03       Impact factor: 6.914

2.  Role of local eosinophilopoietic processes in the development of airway eosinophilia in prednisone-dependent severe asthma.

Authors:  R Sehmi; S G Smith; M Kjarsgaard; K Radford; L-P Boulet; C Lemiere; C M Prazma; H Ortega; J G Martin; P Nair
Journal:  Clin Exp Allergy       Date:  2016-06       Impact factor: 5.018

3.  Eosinophilic oesophagitis endotype classification by molecular, clinical, and histopathological analyses: a cross-sectional study.

Authors:  Tetsuo Shoda; Ting Wen; Seema S Aceves; J Pablo Abonia; Dan Atkins; Peter A Bonis; Julie M Caldwell; Kelley E Capocelli; Christina L Carpenter; Margaret H Collins; Evan S Dellon; Michael D Eby; Nirmala Gonsalves; Sandeep K Gupta; Gary W Falk; Ikuo Hirano; Paul Menard-Katcher; Jonathan T Kuhl; Jeffrey P Krischer; John Leung; Vincent A Mukkada; Jonathan M Spergel; Michael P Trimarchi; Guang-Yu Yang; Nives Zimmermann; Glenn T Furuta; Marc E Rothenberg
Journal:  Lancet Gastroenterol Hepatol       Date:  2018-05-03

4.  Evidence for local eosinophil differentiation within allergic nasal mucosa: inhibition with soluble IL-5 receptor.

Authors:  L Cameron; P Christodoulopoulos; F Lavigne; Y Nakamura; D Eidelman; A McEuen; A Walls; J Tavernier; E Minshall; R Moqbel; Q Hamid
Journal:  J Immunol       Date:  2000-02-01       Impact factor: 5.422

5.  Longitudinal Evaluation of Noninvasive Biomarkers for Eosinophilic Esophagitis.

Authors:  Steve B Min; Cade M Nylund; Thomas P Baker; Mazer Ally; Brian Reinhardt; Yen-Ju Chen; Luz Nazareno; Fouad J Moawad
Journal:  J Clin Gastroenterol       Date:  2017-02       Impact factor: 3.062

6.  Newly developed and validated eosinophilic esophagitis histology scoring system and evidence that it outperforms peak eosinophil count for disease diagnosis and monitoring.

Authors:  M H Collins; L J Martin; E S Alexander; J Todd Boyd; R Sheridan; H He; S Pentiuk; P E Putnam; J P Abonia; V A Mukkada; J P Franciosi; M E Rothenberg
Journal:  Dis Esophagus       Date:  2017-02-01       Impact factor: 3.429

7.  Eosinophil progenitor levels are increased in patients with active pediatric eosinophilic esophagitis.

Authors:  David W Morris; Emily M Stucke; Lisa J Martin; J Pablo Abonia; Vincent A Mukkada; Philip E Putnam; Marc E Rothenberg; Patricia C Fulkerson
Journal:  J Allergy Clin Immunol       Date:  2016-05-16       Impact factor: 10.793

Review 8.  Pediatric inflammatory bowel disease: is it different?

Authors:  Arie Levine
Journal:  Dig Dis       Date:  2009-09-24       Impact factor: 2.404

9.  CD34+ hemopoietic progenitor cells are potent effectors of allergic inflammation.

Authors:  Zoulfia Allakhverdi; Michael R Comeau; Dirk E Smith; Dean Toy; Leandra Mfuna Endam; Martin Desrosiers; Yong-Jun Liu; Karen J Howie; Judah A Denburg; Gail M Gauvreau; Guy Delespesse
Journal:  J Allergy Clin Immunol       Date:  2008-12-06       Impact factor: 10.793
  9 in total
  8 in total

1.  Noninvasive Diagnosis of Eosinophilic Esophagitis: The Nuclear Medicine Option.

Authors:  Benjamin L Wright; Hirohito Kita
Journal:  Mayo Clin Proc       Date:  2020-03       Impact factor: 7.616

Review 2.  Eosinophilic Esophagitis: Existing and Upcoming Therapies in an Age of Emerging Molecular and Personalized Medicine.

Authors:  Ian F Slack; Justin T Schwartz; Vincent A Mukkada; Shawna Hottinger; J Pablo Abonia
Journal:  Curr Allergy Asthma Rep       Date:  2020-06-06       Impact factor: 4.806

Review 3.  The genetic etiology of eosinophilic esophagitis.

Authors:  Leah C Kottyan; Sreeja Parameswaran; Matthew T Weirauch; Marc E Rothenberg; Lisa J Martin
Journal:  J Allergy Clin Immunol       Date:  2020-01       Impact factor: 10.793

Review 4.  Models and Tools for Investigating Eosinophilic Esophagitis at the Bench.

Authors:  Amiko M Uchida; Gabrielle Ro; John J Garber; Kathryn A Peterson; June L Round
Journal:  Front Immunol       Date:  2022-07-06       Impact factor: 8.786

5.  Noninvasive biomarkers identify eosinophilic esophagitis: A prospective longitudinal study in children.

Authors:  Joshua B Wechsler; Steven J Ackerman; Mirna Chehade; Katie Amsden; Mary E Riffle; Ming-Yu Wang; Jian Du; Matt L Kleinjan; Preeth Alumkal; Elizabeth Gray; Kwang-Youn A Kim; Barry K Wershil; Amir F Kagalwalla
Journal:  Allergy       Date:  2021-05-10       Impact factor: 14.710

Review 6.  Non-invasive biomarkers of eosinophilic esophagitis.

Authors:  Martina Votto; Maria De Filippo; Riccardo Castagnoli; Francesco Delle Cave; Francesca Giffoni; Viola Santi; Marta Vergani; Carlo Caffarelli; Mara De Amici; Gian Luigi Marseglia; Amelia Licari
Journal:  Acta Biomed       Date:  2021-11-29

7.  Human differentiated eosinophils release IL-13 in response to IL-33 stimulation.

Authors:  Amiko M Uchida; Gabrielle Ro; Li Qiang; Kathryn A Peterson; June Round; Michael Dougan; Stephanie K Dougan
Journal:  Front Immunol       Date:  2022-09-13       Impact factor: 8.786

8.  Monitoring Eosinophilic Esophagitis Disease Activity With Blood Eosinophil Progenitor Levels.

Authors:  Anna Henderson; Adam Magier; Justin T Schwartz; Lisa J Martin; Margaret H Collins; Philip E Putnam; Vincent A Mukkada; J Pablo Abonia; Marc E Rothenberg; Patricia C Fulkerson
Journal:  J Pediatr Gastroenterol Nutr       Date:  2020-04       Impact factor: 3.288
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.